I listened to the latest episode of the Acquired podcast today, March 10, 2024. It hasn't been posted to Apple podcasts yet, but it is on their website.
From the acquired.fm page for the episode:
On this episode, we dive into the science of the molecule semaglutide (and its predecessor liraglutide) with the world expert on the topic, Lotte Bjerre Knudsen. Lotte is Novo Nordisk’s Chief Scientific Advisor and led the research group back in the early 1990s that first invented the molecule. A few topics from our conversation:
- The science behind what is happening in the body that causes weight loss while on Ozempic
- What it was like in the 1990s and 2000s believing in a drug for a problem that the rest of the industry (including her own company) had written off
- How weight loss was actually a goal from the very start — not just a side effect of diabetes medication like you often read today!
It's interesting. Lotte Bjerre Knudsen has a talent for communicating in-depth scientific data in a way the public understands and can engage with.
What are your thoughts on the future of weight loss medications such as Ozempic?
Tune in to this fascinating episode to discover the science behind Ozempic and its impact on weight loss and diabetes treatment.
#AcquiredPodcast #Ozempic #WeightLoss #ScienceCommunication
